Paying for Covid pills will soon shift to insurers
WASHINGTON — The Biden administration is slowly shifting millions of Covid-19 treatments to private insurers and drugmakers, starting next week.
The transition to commercial payers and providers will begin Nov. 1 but last through at least December as providers dole out existing stock, Health and Human Services Secretary Xavier Becerra wrote in a letter issued Friday. That includes Pfizer’s Paxlovid, which the government will stop ordering on Nov. 10, and Merck’s Lagevrio, which will be open for provider orders through Dec. 15.
Read Original Article: Paying for Covid pills will soon shift to insurers »
